News
Videos
Conferences
Events
Resources
Subscribe

News|Videos|April 20, 2016

Testing Procedures and Considerations

Episodes in this series

EP. 1 Types of Multiple Myeloma

EP. 1 Types of Multiple Myeloma

EP. 2 Testing Procedures and Considerations

EP. 2 Testing Procedures and Considerations

EP. 3 Considerations For Treatment

EP. 3 Considerations For Treatment

EP. 4 Monitoring Patients

EP. 4 Monitoring Patients

EP. 5 Top Considerations for Maintenance Therapy

EP. 5 Top Considerations for Maintenance Therapy

EP. 6 New Drug Classes For Treatment

EP. 6 New Drug Classes For Treatment

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 7 Clinical Trials and Stem Cell Transplants

EP. 8 Professional Expectations for Future

EP. 8 Professional Expectations for Future

Newsletter

Stay up to date on cancer updates, research and education

Related Content

Dr. Anne Peled

Breast Cancer Surgeon and Survivor Undergoes Nerve-Sparing Procedure

January 27th 2026

The FDA granted breakthrough therapy designation to bezuclastinib plus Sutent for patients with gastrointestinal stromal tumors following progression.

FDA Grants Designation to Bezuclastinib Combo in Advanced GIST

January 27th 2026

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

January 27th 2026

Dr. Anne Peled

Two-Time Breast Cancer Survivor Shares Advice for Fellow Patients

ByDr. Anne Peled

January 27th 2026

Debbie Legault

Cancer and Answering the Phone

ByDebbie Legault

January 27th 2026

Trending on CURE

Tests May Predict Chemo Benefit in Breast Cancer

FDA Approves Darzalex Faspro-VRd For Newly Diagnosed, Transplant Ineligible Multiple Myeloma

ctDNA Levels May Predict Treatment Response in Advanced Breast Cancer

FDA Fast Tracks IBI3003 For Relapsed/Refractory Myeloma

Beyond Statistics: Lessons in Mindset and Action from a Cancer Survivor